ATG2B overexpression is correlated with poor RFS in Tamoxifen treatedbreast cancer patients, having p-value=0.017 and HR=0.69 (0.51-0.94) (Table 1 - see PDF) (Figure 3C). This evidence concerns the gene ATG2B and cancer.